Alternatives to Acarbose If You Can't Fill Your Prescription

Acarbose (formerly brand name Precose) is an alpha-glucosidase inhibitor used to manage blood sugar after meals in adults with type 2 diabetes. When your pharmacy doesn't have it in stock, it's important to know your options — and to act quickly so you don't miss doses. Here's a clear rundown of acarbose alternatives your doctor may consider in 2026.

Important: Never stop or switch your diabetes medication without talking to your doctor first. The alternatives below are intended to start a conversation with your prescriber, not to guide self-treatment.

How Does Acarbose Work? (Understanding What to Replace)

Acarbose works by blocking enzymes in your small intestine that break down carbohydrates into simple sugars. This slows glucose absorption after meals, reducing postprandial (post-meal) blood sugar spikes. It doesn't cause insulin release and rarely causes hypoglycemia on its own. Any good alternative needs to address postprandial glucose control — or compensate through another mechanism.

Alternative #1: Miglitol (Glyset) — The Closest Equivalent

Miglitol (brand: Glyset) is another FDA-approved alpha-glucosidase inhibitor that works almost identically to acarbose. It targets the same intestinal enzymes and produces similar reductions in postprandial glucose. The main differences are in pharmacokinetics: miglitol is more completely absorbed systemically, which matters for patients with kidney disease.

If you're switching from acarbose, miglitol is the most clinically similar option. However, it may be just as difficult to find at some pharmacies since it is also a low-volume medication.

Alternative #2: Metformin (Glucophage) — The Go-To First-Line Drug

Metformin is the most widely prescribed diabetes medication in the world and the first-line recommendation from virtually every major diabetes guideline. It works primarily by reducing glucose production in the liver and improving insulin sensitivity. Unlike acarbose, which specifically targets postprandial glucose, metformin has broader effects on fasting glucose as well.

Generic metformin is extremely affordable — as low as $4–$10 per month — and is stocked at virtually every pharmacy in the U.S. If you can tolerate GI side effects (common, especially at first), metformin is usually a seamless swap when combined with guidance from your doctor.

Alternative #3: DPP-4 Inhibitors (Januvia, Tradjenta, Onglyza)

DPP-4 inhibitors like sitagliptin (Januvia), linagliptin (Tradjenta), and saxagliptin (Onglyza) reduce postprandial glucose by increasing the action of natural gut hormones (GLP-1 and GIP) that stimulate insulin release after meals. They share acarbose's postprandial focus and are well-tolerated. They rarely cause hypoglycemia or weight gain — making them a good choice for patients who do well on acarbose's tolerability profile.

DPP-4 inhibitors are significantly more expensive than acarbose ($400–$500/month without insurance), but are widely available and often covered by insurance.

Alternative #4: SGLT2 Inhibitors (Jardiance, Farxiga, Invokana)

SGLT2 inhibitors like empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana) lower blood sugar by causing the kidneys to excrete excess glucose in the urine. They also offer proven heart and kidney protection — a major advantage over acarbose, which doesn't have cardiovascular outcome data to match.

SGLT2 inhibitors are widely available and stocked at most pharmacies. If your doctor has been thinking about adding one to your regimen anyway, an acarbose supply issue might be the moment to make the switch.

Alternative #5: GLP-1 Receptor Agonists (Ozempic, Trulicity, Victoza)

GLP-1 receptor agonists like semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) are injectable medications that significantly reduce postprandial glucose and A1C, while also promoting weight loss and protecting the heart and kidneys. They represent a step up in efficacy from acarbose, but require injection and cost significantly more.

If you've been managing well on acarbose, your doctor may prefer a simpler oral switch first. But if your A1C isn't well controlled, a GLP-1 might be a beneficial upgrade.

Quick Comparison of Acarbose Alternatives

Miglitol (Glyset) — Same class, similar GI side effects, hard to find, not controlled

Metformin — Most affordable, widely available, fasting + postprandial benefit, may cause GI upset

DPP-4 inhibitors (Januvia, Tradjenta) — Well tolerated, postprandial focus, expensive without insurance

SGLT2 inhibitors (Jardiance, Farxiga) — Broad glycemic benefit + heart/kidney protection, oral daily, widely stocked

GLP-1 agonists (Ozempic, Trulicity) — Highest efficacy for A1C + weight loss, injectable, most expensive

First, Try to Find Your Acarbose

Before switching medications, it's worth checking whether acarbose is simply out of stock at your specific pharmacy. medfinder can call pharmacies in your area to locate it for you. If it's available nearby, that may be faster than arranging a prescription change with your doctor.

Related: How to Find Acarbose in Stock Near You (Tools + Tips)